Position in LLY
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,386,432,781
-$364,705,778 QoQ
Shares Held
1,507,369
-7.5% QoQ
Ownership
0.160%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Mar 31, 2025CallValue
$10,323,875
CallShares
12,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026BANK OF MONTREAL /CAN/ holds $5,682,625,272 across 16 Drug Manufacturers - General names. LLY ranks #1 (24.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
1,507,369 | $1,386,432,781 | |
| 2 | JNJ |
Johnson & Johnson
|
4,514,106 | $1,103,428,067 | |
| 3 | ABBV |
AbbVie Inc.
|
3,078,495 | $669,541,874 | |
| 4 | MRK |
Merck & Co., Inc.
|
4,831,161 | $581,140,353 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
3,549,224 | $494,655,344 | |
| 6 | AZN |
Astrazeneca PLC
|
1,926,315 | $379,907,840 | |
| 7 | AMGN |
Amgen Inc
|
961,165 | $338,185,902 | |
| 8 | GSK |
GSK plc
|
4,639,799 | $256,070,504 |
All Filings in LLY
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,386,432,781 | 1,507,369 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,751,138,559 | 1,629,451 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $1,197,846,671 | 1,569,917 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,124,267,783 | 1,442,238 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $1,258,171,468 | 1,523,376 | Shares | Defined | 2025-05-13 | |
| 2025-03-31 | $10,323,875 | 12,500 | Call | Defined | 2025-05-13 | |
| 2024-12-31 | $1,283,830,596 | 1,662,993 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,675,629,702 | 1,891,358 | Shares | Defined | 2024-11-13 | |
| 2024-09-30 | $30,919,306 | 34,900 | Put | Defined | 2024-11-13 | |
| 2024-06-30 | $1,665,120,571 | 1,839,140 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,410,427,473 | 1,812,982 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,117,072,327 | 1,916,339 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $927,106,787 | 1,726,038 | Shares | Defined | 2023-11-01 | |
| 2023-06-30 | $11,724,500 | 25,000 | Call | Defined | 2023-08-02 | |
| 2023-06-30 | $916,038,463 | 1,953,257 | Shares | Defined | 2023-08-02 | |
| 2023-03-31 | $563,773,723 | 1,641,645 | Shares | Defined | 2024-06-13 | |
| 2022-12-31 | $15,621,368 | 42,700 | Put | Defined | 2023-02-01 | |
| 2022-12-31 | $622,841,501 | 1,702,497 | Shares | Defined | 2023-02-01 | |
| 2022-09-30 | $501,943,964 | 1,552,324 | Shares | Defined | 2022-11-10 | |
| 2022-09-30 | $323,350 | 1,000 | Put | Defined | 2022-11-10 | |
| 2022-09-30 | $129,340 | 400 | Call | Defined | 2022-11-10 | |
| 2022-06-30 | $514,226,507 | 1,585,993 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $376,752,376 | 1,315,614 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $420,693,830 | 1,523,039 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $506,438,029 | 2,191,898 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $501,876,919 | 2,186,637 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $364,102,647 | 1,948,949 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $414,300,937 | 2,453,808 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $340,781,261 | 2,302,265 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $392,381,657 | 2,389,948 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $371,970,879 | 2,681,451 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||